View More Recent Stories

Apr 1, 2022 09:00AM Praxis Precision Medicines to Present Data from PRAX-944 for Essential Tremor at 2022 American Academy of Neurology Annual Meeting
Mar 21, 2022 09:00AM Praxis Precision Medicines to Present at Stifel’s 4th Annual CNS Day
Mar 1, 2022 09:00AM Praxis Precision Medicines to Present at Cowen’s 42nd Annual Healthcare Conference
Feb 28, 2022 06:00AM Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Feb 22, 2022 09:00AM Praxis Precision Medicines to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022
Jan 18, 2022 09:00AM Praxis Precision Medicines Announces Publication of Preclinical Data Highlighting Differentiated and Potent Antiepileptic Activity of PRAX-562
Dec 10, 2021 11:00AM Praxis Precision Medicines to Host Movement Disorder Day on December 17, 2021
Dec 2, 2021 07:00AM Praxis Precision Medicines Announces Management Team Appointments
Nov 29, 2021 08:00AM Praxis Precision Medicines to Present Data from Rare Disease Programs at the American Epilepsy Society 2021 Annual Meeting
Nov 24, 2021 09:00AM Praxis Precision Medicines to Present at Piper Sandler’s 33rd Annual Virtual Healthcare Conference
Nov 3, 2021 07:00AM Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Oct 22, 2021 09:00AM Praxis Precision Medicines To Provide Corporate Update And Report Third Quarter 2021 Financial Results On Wednesday, November 3, 2021
Sep 1, 2021 09:00AM Praxis Precision Medicines to Present at Citi’s 16th Annual BioPharma Virtual Conference
Aug 16, 2021 08:00AM Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Aug 16, 2021 07:55AM Praxis Precision Medicines Reports PRAX-114 Perimenopausal Depression (PMD) Phase 2a Proof-of-Concept Trial Results and Announces Plans to Advance to Phase 2b Study in Women with Menopausal and Mood S
Aug 2, 2021 09:00AM Praxis Precision Medicines to Present at 2021 Wedbush PacGrow Healthcare Conference
Jul 6, 2021 09:00AM Praxis Precision Medicines to Present at Upcoming Investor Conferences
May 25, 2021 08:03AM Praxis Precision Medicines (PRAX) Announces Tim Kelly as CFO
May 25, 2021 08:00AM Praxis Precision Medicines Appoints Tim Kelly as Chief Financial Officer
May 14, 2021 09:00AM Praxis Precision Medicines to Present at Upcoming Investor Conferences
May 11, 2021 08:00AM Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2021 Financial Results
Apr 30, 2021 09:01AM Praxis Precision Medicines (PRAX) Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEE
Apr 30, 2021 09:00AM Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEE
Apr 29, 2021 08:00AM Praxis Precision Medicines Adds Neurology Expertise to Board of Directors with Appointment of Merit Cudkowicz, M.D.
Apr 15, 2021 04:05PM Praxis Precision Medicines Adds Development Expertise to Board of Directors with Appointment of Jeffrey Chodakewitz, M.D.
Apr 14, 2021 09:07AM Praxis Precision Medicines (PRAX) Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE
Apr 14, 2021 09:00AM Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE
Mar 24, 2021 08:00AM Praxis Precision Medicines to Present at Stifel’s 3rd Annual CNS Day
Mar 17, 2021 07:00AM Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
View More Recent Stories